KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Neogenomics (NEO) Asset Utilization Ratio (2016 - 2026)

Neogenomics filings provide 16 years of Asset Utilization Ratio readings, the most recent being 0.55 for Q1 2026.

  • On a quarterly basis, Asset Utilization Ratio rose 32.8% to 0.55 in Q1 2026 year-over-year; TTM through Mar 2026 was 0.55, a 32.8% increase, with the full-year FY2025 number at 0.49, up 21.91% from a year prior.
  • Asset Utilization Ratio hit 0.55 in Q1 2026 for Neogenomics, up from 0.53 in the prior quarter.
  • In the past five years, Asset Utilization Ratio ranged from a high of 0.55 in Q1 2026 to a low of 0.26 in Q1 2022.
  • Median Asset Utilization Ratio over the past 5 years was 0.37 (2024), compared with a mean of 0.38.
  • Biggest five-year swings in Asset Utilization Ratio: crashed 56.03% in 2022 and later surged 32.8% in 2026.
  • Neogenomics' Asset Utilization Ratio stood at 0.29 in 2022, then increased by 20.77% to 0.35 in 2023, then rose by 14.38% to 0.4 in 2024, then soared by 32.03% to 0.53 in 2025, then grew by 3.63% to 0.55 in 2026.
  • The last three reported values for Asset Utilization Ratio were 0.55 (Q1 2026), 0.53 (Q4 2025), and 0.51 (Q3 2025) per Business Quant data.